UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 15
CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF
THESECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER
SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934.

Commission File Number: 000-55856

Kelvin Medical, Inc.

(Exact name of registrant as specified in its charter)

              10930 SkyRanch Place, Nevada City, CA 95959                    
Tel: (530) 388-8706
(Address, including zip code, and telephone number, including area code,
of registrant’s principal executive offices)

Common stock, $0.001 par value                                           
(Title of each class of securities covered by this Form)

None                                                                                  
(Titles of all other classes of securities for which a duty to file
reports under section 13(a) or 15(d) remains)


Please place an X in the box(es) to designate the appropriate rule
provision(s) relied upon to terminate or suspend the duty to file
reports:
     Rule 12g-4(a)(1)[X]
     Rule 12g-4(a)(2)[]
     Rule 12h-3(b)(1)(i)[X]
     Rule 12h-3(b)(1)(ii)[]
     Rule 15d-6[]

Approximate number of holders of record as of the certification or
notice date: 47                                                        

Pursuant to the requirements of the Securities Exchange Act of 1934,
Kelvin Medical, Inc. has caused this certification/notice to be signed
on its behalf by the undersigned duly authorized person.

Date: July 30, 2018                              By: /s/ William Mandel
                                                          Name: William Mandel
                                                          Title: Chief Executive Officer